» Articles » PMID: 11684441

The Many Faces of Metalloproteases: Cell Growth, Invasion, Angiogenesis and Metastasis

Overview
Specialty Cell Biology
Date 2001 Oct 31
PMID 11684441
Citations 221
Authors
Affiliations
Soon will be listed here.
Abstract

Metalloproteases are important in many aspects of biology, ranging from cell proliferation, differentiation and remodeling of the extracellular matrix (ECM) to vascularization and cell migration. These events occur several times during organogenesis in both normal development and during tumor progression. Mechanisms of metalloprotease action underlying these events include the proteolytic cleavage of growth factors so that they can become available to cells not in direct physical contact, degradation of the ECM so that founder cells can move across tissues into nearby stroma, and regulated receptor cleavage to terminate migratory signaling. Most of these processes require a delicate balance between the functions of matrix metalloproteases (MMPs) or metalloprotease-disintegrins (ADAMs) and natural tissue inhibitors of metalloproteases (TIMPs). In this review, we discuss recent progress in identifying an essential role for metalloproteases in axon outgrowth, as an example of a focal invasive event. We also discuss the evolving concept of how MMPs might regulate stem cell fate during tumor development.

Citing Articles

Deciphering the synergistic role of tyrosyl-tRNA synthetase 1 and yes-associated protein 1: Catalysts of malignant progression in hepatocellular carcinoma.

Zhou L, Zhang X, Zhang C, Wang Y, Zhang J, Wang Y Cytojournal. 2025; 21:66.

PMID: 39917005 PMC: 11801646. DOI: 10.25259/Cytojournal_91_2024.


Unraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine.

Cassani M, Fernandes S, Pagliari S, Cavalieri F, Caruso F, Forte G Adv Sci (Weinh). 2024; 12(2):e2409898.

PMID: 39629891 PMC: 11727388. DOI: 10.1002/advs.202409898.


Granzymes in health and diseases: the good, the bad and the ugly.

Cigalotto L, Martinvalet D Front Immunol. 2024; 15():1371743.

PMID: 38646541 PMC: 11026543. DOI: 10.3389/fimmu.2024.1371743.


Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).

Li K, Li D, Hafez B, Bekhit M, Bin Jardan Y, Alanazi F Oncol Res. 2024; 32(4):737-752.

PMID: 38560573 PMC: 10972725. DOI: 10.32604/or.2023.042925.


Eosinophilic Chronic Rhinosinusitis and Pathogenic Role of Protease.

Kim J, Kwak S, Lee J, Park I, Lee S, Shin J Int J Mol Sci. 2023; 24(24).

PMID: 38139201 PMC: 10744023. DOI: 10.3390/ijms242417372.


References
1.
Soloway P, Alexander C, Werb Z, Jaenisch R . Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene. 1996; 13(11):2307-14. View

2.
Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y . Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997; 16(13):3898-911. PMC: 1170014. DOI: 10.1093/emboj/16.13.3898. View

3.
Werb Z . ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997; 91(4):439-42. DOI: 10.1016/s0092-8674(00)80429-8. View

4.
Zuo J, Ferguson T, Hernandez Y, Stetler-Stevenson W, Muir D . Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci. 1998; 18(14):5203-11. PMC: 6793496. View

5.
Goss K, Brown P, Matrisian L . Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Int J Cancer. 1998; 78(5):629-35. DOI: 10.1002/(sici)1097-0215(19981123)78:5<629::aid-ijc17>3.0.co;2-8. View